Results 191 to 200 of about 4,769,368 (347)

Total Ischaemic Burden European Trial (TIBET): Effects of ischaemia and treatment with atenolol, nifedipine SR and their combination on outcome in patients with chronic stable angina [PDF]

, 1996
Henry J. Dargie, Ian Ford, Kim Fox
openalex   +1 more source

Comprehensive omics‐based classification system in adult patients with B‐cell acute lymphoblastic leukemia

Molecular Oncology, EarlyView.
The COMBAT classification system, developed through multi‐omics integration, stratifies adult patients with B‐cell acute lymphoblastic leukemia(B‐ALL) into three molecular subtypes with distinct surface antigen patterns, immune landscape, methylation patterns, biological pathways and prognosis.
Yang Song, Ting Liu, Qishan Hao, Qiuyun Fang, Xiaoyuan Gong, Yan Li, Zheng Tian, Hui Wei, Min Wang, Jianxiang Wang, Tao Cheng, Yingchang Mi   +11 more
wiley   +1 more source

Clinical and radiological profile of tuberculosis and treatment outcome in patients ≤18 years: A prospective study. [PDF]

J Family Med Prim Care
Madhuri K, Subhankar S, Mohapatra AK, Jagaty SK, Behera D, Das A, Parida S, Mishra S.   +7 more
europepmc   +1 more source

Coronary atherectomy in acute ischemic syndromes: Implications of thrombus on treatment outcome

, 1991
Barry Kramer, Timothy J. Larkin, Paulette Niemyski, Michele Parker   +3 more
openalex   +1 more source

B cell lymphoproliferative disorders following hematopoietic stem cell transplantation: risk factors, treatment and outcome [PDF]

, 1999
TG Gross, M. Steinbuch, Todd E. DeFor, RS Shapiro, Philip B. McGlave, NKC Ramsay, JE Wagner, A.H. Filipovich   +7 more
openalex   +1 more source

Circulating tumor DNA monitoring and blood tumor mutational burden in patients with metastatic solid tumors treated with atezolizumab

Molecular Oncology, EarlyView.
In patients treated with atezolizumab as a part of the MyPathway (NCT02091141) trial, pre‐treatment ctDNA tumor fraction at high levels was associated with poor outcomes (radiographic response, progression‐free survival, and overall survival) but better sensitivity for blood tumor mutational burden (bTMB).
Charles Swanton, Russell W. Madison, Candice Francheska B. Tambaoan, Funda Meric‐Bernstam, Christopher J. Sweeney, Razelle Kurzrock, Howard A. Burris III, David R. Spigel, Hanna Tukachinsky, Jason Hughes, Julia Malato, Bongin Yoo, Tania Szado, Cheryl Schwab, Lincoln W. Pasquina, Amaya Gasco, Katja Schulze, Claire F. Friedman   +17 more
wiley   +1 more source

Serum Neurofilament Light Chain as a Biomarker for CIDP Diagnosis, Severity, and Treatment Outcome. [PDF]

Neurol Neuroimmunol Neuroinflamm
Klimas R, Kohle F, Horstkemper L, Benkert P, Rehm A, Seibert A, Riesner M, Sgodzai M, Grüter T, Rilke N, Gisevius B, Beyer L, Gerwert K, Kuhle J, Schroeter M, Lehmann HC, Gold R, Fisse AL, Motte J, Pitarokoili K.   +19 more
europepmc   +1 more source

Role of Psychosocial Treatments in Management of Schizophrenia: A Meta-Analytic Review of Controlled Outcome Studies [PDF]

, 1998
Ramin Mojtabai, R. Nicholson, B. N. Carpenter   +2 more
openalex   +1 more source

Dose‐dependent induction of epithelial‐mesenchymal transition in 3D melanoma models by non‐thermal plasma treatment

Molecular Oncology, EarlyView.
Non‐thermal plasma treatment of melanoma cells induced epithelial‐mesenchymal transition (EMT) in a dose‐dependent fashion. This report highlights the critical need to further investigate potential adverse effects of non‐thermal plasma for cancer therapy and to optimize treatment parameters for clinical translation. Despite the promising results of non‐
Eline Biscop, Edgar Cardenas De La Hoz, Hanne Verswyvel, Joey De Backer, Ho Wa Lau, Angela Privat‐Maldonado, Wim Vanden Berghe, Steve Vanlanduit, Evelien Smits, Annemie Bogaerts, Abraham Lin   +10 more
wiley   +1 more source

The association between patient engagement and treatment outcome in guided internet-delivered CBT for anxiety and depression. [PDF]

Front Psychol
Hammerfald K, Jahren HH, Solbakken OA.
europepmc   +1 more source